CARB-X Funding Round 3 for Diagnostics will be open for Expressions of Interest (EOI) August 12 – August 19, 2019, 5 PM ET. Expressions of Interest (EOI) accepted online only: The scope of Round 3 is restricted to diagnostics that will rapidly identify either the bacterial species or antibiotic susceptibility, or both. Only pathogen ID/AST approaches are in scope, as per the pathogens below. Host-biomarker approaches are not in scope. Pathogen Scope: Acinetobacter baumannii, carbapenem-R; Pseudomonas aeruginosa, carbapenem-R; Enterobacteriaceae, carbapenem-R, 3rd-gen ceph-R (ESBL+); Enterococcus faecium, vancomycin-R; Staphylococcus aureus, methicillin-R, vancomycin-I/R; Campylobacter spp., fluoroquinolone-R; Salmonellae spp., fluoroquinolone-R; Neisseria gonorrhoeae, 3rd-gen ceph-R, fluoroquinolone-R; Streptococcus pneumoniae, penicillin-NS; Shigella spp., fluoroquinolone-R; Clostridium difficile; Group A Streptococcus; Group B Streptococcus
Deadline override 12 August 2019